MXPA04003931A - Pronostico de cancer de mama. - Google Patents

Pronostico de cancer de mama.

Info

Publication number
MXPA04003931A
MXPA04003931A MXPA04003931A MXPA04003931A MXPA04003931A MX PA04003931 A MXPA04003931 A MX PA04003931A MX PA04003931 A MXPA04003931 A MX PA04003931A MX PA04003931 A MXPA04003931 A MX PA04003931A MX PA04003931 A MXPA04003931 A MX PA04003931A
Authority
MX
Mexico
Prior art keywords
breast cancer
cancer prognostics
prognostics
microarrays
prognosis
Prior art date
Application number
MXPA04003931A
Other languages
English (en)
Inventor
Yixin Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA04003931A publication Critical patent/MXPA04003931A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Un metodo para proveer un pronostico de cancer de mama se realiza al analizar la expresion de un grupo de genes; se incluyen perfiles de expresion genica en una variedad de medios tales como microdisposiciones, asi como equipos que los contienen.
MXPA04003931A 2003-04-24 2004-04-26 Pronostico de cancer de mama. MXPA04003931A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/422,522 US7306910B2 (en) 2003-04-24 2003-04-24 Breast cancer prognostics

Publications (1)

Publication Number Publication Date
MXPA04003931A true MXPA04003931A (es) 2004-11-29

Family

ID=32962443

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003931A MXPA04003931A (es) 2003-04-24 2004-04-26 Pronostico de cancer de mama.

Country Status (10)

Country Link
US (2) US7306910B2 (es)
EP (1) EP1471154A3 (es)
JP (1) JP2004344171A (es)
KR (1) KR20040096423A (es)
CN (1) CN1715421A (es)
AR (1) AR044099A1 (es)
AU (2) AU2004201706A1 (es)
BR (1) BRPI0403290A (es)
CA (1) CA2462747A1 (es)
MX (1) MXPA04003931A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
KR100763902B1 (ko) * 2004-02-20 2007-10-05 삼성전자주식회사 유방암 특이적 단백질, 그를 코딩하는 유전자, 및 상기단백질 또는 유전자를 이용한 유방암의 진단 방법
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
CA2603898A1 (en) * 2005-04-04 2006-10-12 Veridex, Llc Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways
EP1983046A4 (en) * 2006-02-03 2009-03-25 Messengerscape Co Ltd GENERAL GROUP APPLICABLE TO CANCER PROSTICE
WO2008094678A2 (en) * 2007-01-31 2008-08-07 Applera Corporation A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
WO2008123867A1 (en) * 2007-04-05 2008-10-16 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of breast cancer
CN102016881B (zh) * 2008-04-25 2013-06-12 皇家飞利浦电子股份有限公司 样本数据的分类
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
EP2391962B1 (en) 2009-01-28 2016-12-21 University of Notre Dame du Lac Accelerated progression relapse test
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
KR101421326B1 (ko) * 2010-03-30 2014-07-21 서울대학교산학협력단 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
WO2013159099A2 (en) * 2012-04-20 2013-10-24 Memorial Sloan-Kettering Cancer Center Gene expression profiles associated with metastatic breast cancer
GB201510684D0 (en) * 2015-06-17 2015-08-05 Almac Diagnostics Ltd Gene signatures predictive of metastatic disease
CN110172461B (zh) * 2019-06-03 2023-05-09 上海长征医院 一种新型骨肉瘤肺转移模型的构建方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500010A (ja) 1997-12-23 2002-01-08 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ｉ
WO2002010436A2 (en) 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Prognostic classification of breast cancer
WO2002068579A2 (en) 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
AU2002253878A1 (en) 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
ATE503023T1 (de) * 2001-06-18 2011-04-15 Rosetta Inpharmatics Llc Diagnose und prognose von brustkrebspatientinnen
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
WO2004079014A2 (en) 2003-03-04 2004-09-16 Arcturus Bioscience, Inc. Signatures of er status in breast cancer

Also Published As

Publication number Publication date
US7306910B2 (en) 2007-12-11
CN1715421A (zh) 2006-01-04
US20100009861A1 (en) 2010-01-14
EP1471154A3 (en) 2005-02-09
US8183353B2 (en) 2012-05-22
BRPI0403290A (pt) 2005-07-12
JP2004344171A (ja) 2004-12-09
AR044099A1 (es) 2005-08-24
AU2004201761A1 (en) 2004-11-11
US20040214179A1 (en) 2004-10-28
EP1471154A2 (en) 2004-10-27
AU2004201706A1 (en) 2004-11-11
KR20040096423A (ko) 2004-11-16
CA2462747A1 (en) 2004-10-24

Similar Documents

Publication Publication Date Title
WO2005083429A8 (en) Breast cancer prognostics
WO2006060653A3 (en) Lung cancer prognostics
EP2333112A3 (en) Breast cancer prognostics
EP1526186A3 (en) Colorectal cancer prognostics
MXPA04003931A (es) Pronostico de cancer de mama.
Donnem et al. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
Allison Molecular pathology of breast cancer: what a pathologist needs to know
MXPA03002862A (es) Panel de diagnostico del cancer.
WO2005039382A3 (en) Prediction of likelihood of cancer recurrence
EP2392678A3 (en) Prognosis prediction for colorectal cancer
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2005100606A3 (en) Gene expression markers for predicting response to chemotherapy
WO2006012646A3 (en) Amacr cancer markers
EP1492440A4 (en) NEW PROCEDURE FOR THE DIAGNOSIS AND FORECAST OF MALIGNES DISEASES
NZ594003A (en) Cancer biomarkers
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
ATE483979T1 (de) Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa
HK1145342A1 (en) Prognosis prediction for melanoma cancer
MXPA03002863A (es) Valoracion de cancer colorrectal.
MXPA03002866A (es) Valoracion de cancer colorrectal.
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
MX2012003329A (es) Metodo para identificar si un paciente respondera o no a la inmunoterapia.
BRPI0403812A (pt) Prognósticos de câncer coloretal
DE10345021A1 (de) Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
ATE466958T1 (de) Klassifizierung von kolonkrebs

Legal Events

Date Code Title Description
FA Abandonment or withdrawal